arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

Saturday 24 September

Please find below the programme schedule for Saturday 24 September 2022.

Saturday 24 Sep

Meet the experts session 3

08:00

M3.1 Common errors in clinical mycology

Alessandro C. Pasqualotto, Brazil and O.C. Abraham, India

08:00

M3.2 Common errors in Medical Mycology laboratory

Donald Sheppard, Canada

09:00

Key note (P8): Challenges in the diagnosis & management of fungal infections in developing countries

Arnaldo Lopes Colombo, Brazil

10:00

Break

Parallel session 10

Parallel session 10 will take place from 10:30 hrs. until 12:00 hrs. and consists of five symposia.

S10.1 Antifungal dosing in children and adolescents

Chair: Andreas Groll, Germany

10:30

S10.1a Dosing of antifungal agents in NICU

TBD

10:50

S10.1b Dosing of antifungal agents in the PICU

Fanny Lanternier, France

11:10

S10.1c Dosing of antifungal agents in the cancer and HSCT setting

Andreas Groll, Germany

11:30

S10.1d Molecular diagnosis and antifungal susceptibility of Colombian clinical isolates of the Sporothrix spp complex

Erika Sánchez Cifuentes, Colombia

11:45

Q&A with all speakers

S10.2 Fungal Infections in Transplant Patients

Chair: Xess Immaculata, India

10:30

S10.2a Fungal infections in solid organ transplant patients

Parikshit Prayag, India

10:50

S10.2b Fungal infections in bone marrow transplant patients

Subramanian Swaminathan, India

11:10

S10.2c Novel approaches in management of fungal infections in transplant infections

Suneetha Narreddy, India

11:30

S10.2d Fungal beta-glucans and mannan performances in HIV-associated histoplasmosis

Antoine Adenis, France

S10.3 The mycobiome characterization: future perspectives or just a trend?

Chair: Jean-Pierre Gangneux, France

10:30

S10.3a Impact of azole therapy on the microbiome and mycobiome of cystic fibrosis patients

Jean-Pierre Gangneux, France

10:50

10.3b Perspectives and limits of lung mycobiome characterization : where are we in 2021?

Francoise Botterel, France

11:10

S10.3c Clinical studies provide new insights on the association between the microbiota and host resistance to Candida albicans intestinal colonization

Margot Delavy, France

11:30

S10.3d Yeast Microbiome in patients with Inflammatory bowel disease (IBD)

Afsane Vaezi, Iran

11:45

Q&A with all speakers

S10.4 Emerging antifungal resistant fungi

Chairs: Koichi Izumikawa, Japan and Yoshitsugu Miyazaki, Japan

10:30

S10.4a New mechanism & diagnositics of azole resistant aspergillosis

Akira watanabe, China, Japan  

10:50

S10.4b Management of chronic pulmonary aspergillosis

Koichi Izumikawa, Japan

11:10

S10.4c Successful treatment of mucormycosis in haematological diseases

Hiroshi Kakeya, Japan 

11:30

S10.4d A unique clinical appearance of Candida auris infection in Japan

Takashi Umeyama, Japan

11:45

Q&A with all speakers

S10.5 Fungal respiratory infections in Cystic Fibrosis

Chairs: Nicolas Papon, France and Benoit Briard, France

S10.5a Fungal respiratory infections in CF patients in the middle East

Mohammad Hedayati, Iran

S10.5b Bacterial-fungal interactions in the CF lung

Benoit Briard, France

11:10

S10.5c Insight into the role of secondary metabolism in the pathogenesis of Scedosporium apiospermum

Nicolas Papon, France

11:30

S10.5d Disseminated pulmonary infection due to Mortierella wolfii in a 6-year-old patient with X-linked CGD receiving MUD-HSCT

Jung-Ho Youn, USA

11:45

Q&A with all speakers

12:00

Closing ceremony